Sun Pharma to acquire Innovcare Lifesciences for $28.7 million - Reuters
Sun Pharma to acquire Innovcare Lifesciences for $28.7 million Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPbW9PcGFxMEREa2p4ajJSYnU3UjdkcmV1WFl0RzVaNjFFNTJiR285akJJMFZLNUlpYWdzV0l0NmdWUkxYYXROYnR3bnBwUm40NnE1SXVlQmpHWWo2QWVPOXc0WThscUxCQnFjbThjVmI4NGRDeGdGNEpmQ001c0E0ZjRmcTluTnBjb3lCN2JZRmNZVVd4V1MtaXhUN1BnY1g5c2JFWEtCY3dod3VSYVE?oc=5" target="_blank">Sun Pharma to acquire Innovcare Lifesciences for $28.7 million</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PMMcKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports - Reuters
McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports Reuters
October 5, 2026 at 09:09 PMIndia's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say - Reuters
India's Aditya Birla unit seeks $1.5 billion in rupee loans to buy Shell arm Solenergi, bankers say Reuters
October 9, 2026 at 06:08 AMCanada's Weston family to buy UK's Boots in $8.9 billion deal - Reuters
Canada's Weston family to buy UK's Boots in $8.9 billion deal Reuters
October 7, 2026 at 04:53 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PM